Boosted darunavir mono therapy works well in two studies

Presented at the IAS conference in Cape town.

Ritonavir-boosted darunavir alone maintains HIV suppression in most patients who achieved an undetectable viral load on combination antiretroviral therapy, according to two studies presented at this conference.

This is important because now patients have another option after combination antiretroviral therapy has gotten to an undetectable viral load level. Maintenance therapy with daurnavir is an acceptable choice as is atazanavir.
Combination therapy to suppress the virus followed by maintenance therapy is becoming a more and more attractive way of treating HIV+ patients, especially those patients that present with low CD 4 levels.